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We have made a new monoclonal antibody, EL-2, and 
used it with an immunorosetting procedure combined 
with Ficoll-Hypaque gradient centrifugation to purify 
and culture basal keratinocytes. Immunofluorescence of 
cell suspensions and immunoperoxidase staining of tis-
sue sections demonstrate that EL-2 reacts with malig-
nant cell lines, activated lymphocytes and monocytes, 
and basal keratinocytes. Sequential immunoprecipita-
tion studies demonstrate that monoclonal antibodies EL-
2 and 4F2 detect the same membrane protein. However, 
we have extended previous studies by making the new 
observation that both EL-2 and 4F2 react with cultured 
melanocytes. 
Basal keratinocytes were purified from single-cell ep-
idermal suspensions by incubation with EL-2 followed 
by rosetting with rabbit antimouse lgG antibodies ~o­
valently linked to bovine red blood cells. Rosettmg 
(basal) keratinocytes were separated from EL-2 n~ga­
tive cells by Ficoll gradient centrifugation. We obtamed 
basal keratinocyte populations of >90% purity as as-
sessed by reactivity with EL-2 and another basal kera-
tinocyte-specific monoclonal antibody, HCI. Langer hans 
cell fibroblast, and melanocyte contamination was neg-
ligible. Cultures of basal keratinocytes were enriched in 
EL-2-reactive cells throughout the entire 19 days of 
culture studied. 
EL-2 is being used to characterize disorders of kera-
tinocyte proliferation; EL-2 reacted with both squamous 
and basal cell carcinomas. EL-2 stained only the basal 
layer of lesional skin from patients with psoriasis, pi-
tyriasis rubra pilaris, and Darier's disease. 
Purification of basal keratinocytes will be important 
in biochemical and functional studies of normal skin and 
in establishing long-term keratinocyte lines from nor-
mal cells. 
Studies of epidermal basal kerat inocytes would be enhanced 
by the availability of suitable a ntibodies that could facilitate 
basal cell separation. Morhenn eta] [1] have reported a panning 
technique for isolating purified basal keratinocytes with two 
basal cell- specific monoclonal a n t ibodies, VM-1 and VM-2. 
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However, panning with VM-1 inhibited subsequent in vitro 
culture of these cells and, a lthough the authors demonstrated 
t hat VM-2-enriched cells could be grown in vitro, only 48-h 
cultures were studied. Other studies have used Percoll gradient 
centrifugation [2,3] velocity sedimentation [ 4], and flow cytom-
etry technology [5] to isolate keratinocyte subpopulations. We 
and others [6-8] have described monoclonal antibodies which 
detect surface membrane antigens shared by subpopulations of 
lymphocytes and epidermal basal keratinocytes. In this report, 
one such monoclonal antibody, specific for basal keratinocytes, 
is used to separate pure popu lations of basal cells from human 
epidermis using a rosetting technique. Our subsequent experi-
ence in successfully culturing t h ese cells will a lso be described. 
MATERIALS AND METHODS 
Cell Lines 
Human cell lines were grown in RPM1-10% feta l calf serum (FCS) 
plus penicillin-streptomycin (100 U/m l) and glu tamine (2 mM) in 5% 
C02 at 37"C. BOL4 was a human T-T hybridoma obtained by fusion 
of 6-day human tetanus toxoid blasts (9] with the hypoxanthine guan-
ine phosphoribosyl transferase-deficient T-cellline KE37 [10]. Human 
melanocytes were cul tured from neonatal foreskin using the method of 
Eisinger and Marko [11] and Horikoshi et al [12]. 
Generation of Monoclonal Antibodies 
~roduction of monoclonal antibodies was performed as follows [13]: 
Bnefly, 20 million BOL4 cells in alum were injected i.p. into BALB/c 
mice (The Jackson Laboratories, Bar Harbor, Maine) at days 1, 21, 
and 29. Three days later, mice were sacrificed, spleen cells ha rvested 
and fused with 10 mil lion SP2/ 0 mouse myeloma cells/spleen usino- the 
technique of Kennett et a l [1 4]. Hybridomas of interest were clon;d in 
soft agar. 
Purification of Monoclona.l Antibody 
BALB/c mice were primed by i.p. injection of0.5 cc pristane (Aldrich 
Chemical Company, Inc. , Milwaukee, Wisconsin) 10- 21 days prior to 
i.p. injection of 106 growing murine hybridoma cells. Purified monoclo-
nal antibody was isolated from ascitic fluid by 45 % ammonium sulfate 
precipitation. Subclass determinat ion was performed by Ouchterlony 
analysis, using rabbit ant imouse immunoglobulin subclass-specific 
antise ra purchased from Miles Biochemicals (Elkhart, Indiana). 
Screening of Hybridoma Supernatants 
Normal hematologic cells, malignant cell lines, cultured keratino-
cytes, melanocytes, and fibroblasts were screened by indirect immu-
nofluorescence [15]. Tetra-methyl-rhodamine isotbiocyanate-conju-
gated Fab' 2 fragments of a goat antimouse JgG antiserum were pur-
chased from Tago Inc. (Burlingame, California). For each data point, 
at least 200 cells were counted using a Leitz Ortholux II fluorescence 
microscope (Leitz, Wetzler, Germany). Keratinocytes, melanocytes, 
and fibroblasts were cul tured on glass coverslips and fixed in phos-
phate-buffered formalin pH 7.0 prior to staining. Immunopreoxidase 
staining of 6 J.Lm-th ick acetone-fixed frozen t issue sections was per-
formed using 3-amino-9 ethylcarbazole (Sigma Chemical Co., St. Louis, 
Missouri) [6,7]. Skin biopsies were taken a fter informed consent was 
obtained in accordance with procedures approved by t he Rockefeller 
University Institutional Review Board. 
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Isolation of Cell Populations 
Periphera l blood mononuclear cells (PBM C) were isolated from 
heparinized blood by Ficoll -Hypaque gradient centrifu gation. T cells 
were isolated by rosetting with neura min idase-treated sheep red blood 
cells (EN). In certa in experiments, T cells were depleted by rosetting 
with EN followed by depletion of monocytes wi th carbonyl iron [15]. 
Monocytes were isolated by adherence of PBMC onto glass covers! ips 
for 45 min at 37'C. Granulocytes were purified by sedimentation in 
Dextran T500 (Pharmacia Fine Chemicals Inc., P iscata way, New Jer-
sey) [7]. 
For certain experiments, T cell -depleted PBMC were incubated in 
plastic fl asks at 2 x 10" cells/ml in RPM! 1640- JO% FCS at 37' C for 
16 h . The nonadherent fract ion was then furth er depleted of monocytes 
with carbonyl iron. This population was further fractionated in to high-
and low-density fractions as desc ribed by Crow and Kunkel [16] as 
follows: 20 million cells were suspended in 100% Percoll (Pharmacia 
Fine Chemicals) . Two millili te rs of 50% Percoll followed by 2 ml of 
30% Percoll were layered onto the 100% Percoll. The tube was cen tri -
fu ged at 2300 rpm for 12 min. The high-density ce lls, enriched in 
resting B lymphocytes, were those obtained from the 50%/100% P ercoll 
in te rphase, a nd the low-den sity cells, enriched in dendritic cells a nd in 
vivo-activated B lymphocytes, were obtai ned from t he 30%/50% Percoll 
in terphase !JG) . 
Isolation of /(eratinocyte Subpopu/ation.s 
Single-cell suspensions of hum an keratinocytes were obtained from 
cadaver skin in cooperation with Dr. Daniel Alonso and Dr. C. Richard 
Minick of The New York Hospita l, Depa rt ment of Pathology as follows. 
B rie!1y, epidermi was separated from dermis using a Goul ian keratome 
(Edward Week and Co. Inc., Research Triangle Park, Nort h Carolina) 
foll owed by incubation with 0.5% trypsi n 1:250 (D ifco, Detroit, Mich-
iga n) for 90 min at 37•c . Epidermal sheets were lifted off the dermis. 
S ingle-cell suspensions were obtai ned by agitation with a glass rod in 
a solu tion of deoxyribonuclease I from bovine pancreas (Sigma Chem-
ical Co.) at a concentration of 25 ,ug/m l and sepa rated from other ti ssue 
material by filtrati on through gauze. Cell popu lations were greate r t ha n 
95% viable by t rypa n blue dye exclusion and typically co ntained less 
than 1% Langerhans cell s, melanocytes, and !ibroblasts as determined 
by OKT6 reactivity, dopa, and leucine a minopeptidase histochemical 
s taining, respecti vely [1 7]. 
Isolation of basa l keratinocytes was perfo rmed using a modified 
rosetting technique. Single-cell suspensions of keratinocytes were in-
cubated ove rnight at4 ·c in keratinocyte cul ture medium (KC M) , which 
consisted of minimum essential medium with Ea rle's salts plus L-
glu tamine and 20% FCS plus hydroco rtisone 0.5 Jlg/ ml, penicillin (100 
U/rn l). streptomycin (100 ,ug/ml), a nd Fungizone (0.25 ,ug/ ml) (Gibco 
Laborato ries, Grand Island, New York). EL-2 reactivity was dimin ished 
by .50% immediately a fter trypsiniza ti on. Therefo re, 20 mi llion unsep-
arated keratinocytes were preincubated overnight at 4 ·c prior to in-
cubation with 0.2 ml undi luted cloned hybridoma EL-2 supernatant for 
1 h at 4 · c followed by 4 washes a nd resuspension in 0.5 ml KCM. 
Affinity-purified rabbit antimouse IgG a ntibodies were covalently at-
tached to bovine red blood cells (bH.BC) as previously described [1 5]. 
A 2% suspension of antibody-coated bRBC (0.5 ml) was added to the 
keratinocytes a nd the mixture pelleted for 10 min a t4 ' C a nd 1000 rpm 
fo llowed by incubation for 1 h on ice. The pellet was gently resuspended 
a nd subjected to l"icoll -Hypaque gradient centrifugation. The inte r-
phase was enriched for antibody-nonreactive keratinocytes, a nd the 
pellet was enriched for EL-2- react.ive (basal) kerati nocytes. bRBC were 
lysed with 0.83% N H,CI, and the rema ining keratinocytes were washed 
in phosphate-buffered saline. In order to assess purity, isolated subpop-
ulat ions were tes ted for reactivity with the basa l keratinocyte-specific 
monoclonal a ntibodies, EL-2 and HC- 1 [7], by ind irect immuno!1uo-
rescence. 
Cell Cultures 
For certa in experiments, lymphocytes were cultured with a 1/200 
dilution of pokeweed mitogen (Gibco Laboratories) [181 or tetanus 
toxoid 40 f< g/ml [9]. Kerat inocytes were cultured in KCM at 37 ' C in a 
5% CO" atmosphere )J 7). 2 X 106 keratinocytes were seeded per 9.6 
em" fl ask (Linbro fl at-bottomed wells, Cat no. 76-058-06, McLean, 
Virgin ia). Medium was changed 3 times per week. At various Limes 
during culture, keraL inocytes were trypsinized with 0.5% t ryps in , 
counted, and incubated for 1 h on ice prior to tes ting lor EL-2 reactivity 
by indirec t immunofluorescence. 
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Membrane l mmunoprecipitation Analysis 
For immunoprecipitation the CEMT cell line was used. These cells 
are strongly positive by immuno!1uorescence wit h the monoclonal 
antibodies EL-2 and 4F2. Cells (50 X 106 ) were radioiodinated with 
lac toperoxidase as descr ibed elsewhere [19], and lysed in 10 mM Tris-
HC!, pH 8.0, 0.5 M NaCl, 0.5 % NP 40, 0.02% Na azide, phenylmethyl-
sulfonyl fluoride 18 11g/ ml (Sigma Chemical Compa ny), and iodoace-
tamide 100 mM at 4 · c. Lysate (50 11!) was absorbed with 25 111 Protein 
A Sepharose CL 4B (Pharmacia Fine Chemicals) and 15 11g ra bbit anti-
muri ne lgG (sham-absorption) or with Protein A Sepharose CL 4B, 
rabbit a nti -murine IgG and 50 ,ug monoclonal antibody, EL-2 or 4F2. 
The lysate was absorbed sequentially 3 times fo r 3 h each at 4' C. 
Thereafter 50 I' I lysate was used for each immunoprecipitation with 25 
Ill Protein A Sepharose CL 4B, 15 ,ug rabbit a ntimurine IgG and 1 of 4 
mur ine monoclonal antibodies [EL-2, 4F2, 9A4 -a monoclonal antibody 
reactive with }32-microglobulin kindly provided by Dr. B. Pernis, and 
FFA85-a monoclonal antibody reactive with T lymphocytes, which 
1mmunoprecipitates a membrane protein of Mr 35,000 (Posnett, unpub-
lished observations)). The immunoprecipitation protocol used has been 
described [19,20]. Immunop recipitates were a nalyzed on a 12.5% poly-
acrylam ide gel under reducing conditions (dithiothreitol 0.1 M). 
RESULTS 
Monoclonal Antibodies EL-2 and 4F2 Detect the Same 
Membrane Protein 
An lgG2 .. K monoclonal antibody, EL-2, was raised by im-
munization with a human T-T hybridoma. Sequential immu-
noprecipitation and immunohistologic studies demonstrated 
that EL-2 detected the same membrane protein as did mono-
clonal antibody 4F2, desc ribed by Haynes and his colleagues 
[8,21 ]. As shown in Table I, EL-2 reacted with a ubiquitous 
antigen on lymphoid and nonlymphoid malignant cell lines, 
monocytes, and antigen- and mitogen -activated lymphocytes. 
In order to determine whether resting or activated B cells 
accounted for the staining seen in the T cell- and monocyte-
depleted PBMC population, Percoll gradient centrifugation was 
performed. In 2 experiments, the low-density (30%/50 % inter-
TABLE l. Reactivity of EL-2 with hematologic and nonhematologic 
cells 






HL60, U937, 1604, K562, A431 
Normal 
Peripheral blood T (4) 
T cell- and monocyte-depleted PBMC (3) 
Low-density T cell - a nd monocyte-depleted 
PBMC (2) ' 
High-density T cell- and monocyte-depleted 
PBMC (2) 1 
Monocytes (2) 
Granulocyt es (2) 
Red blood cells (2) 
Five-day PWM blasts (2) 















"By indirect im munofluorescence using tetra-methyl-rhodam ine-
isoth iocyanate-conjugated Fab' 2 fragments of a goat anti mouse IgG 
antiserum. Numbers in this column represe nt the average % posit ive. 
b Numbers in parentheses denote numbers of separate specimens 
tested. 
' The T-celll ines tested were BOL-4, KE37, Jurkat, MOL T4, CEMT, 
SKW3, HUT78. 
<~The B-cell lines tested were 1899, GM4154A, CESS, 0467, 2p68, 
EB3, 8866, 32Al. 
• 30- 50% Percol l interphase from T cell - and monocyte-depleted 
PBMC. 
150- 100% Percoll interphase from T cell - a nd monocyte-depleted 
PBMC. 
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phase) fract ion, enriched in activated B cells [16], was 5~% 
ctive with EL-2. In contrast, only 8% of t he high-density (~~%/100% in te~p_hase) fraction , _enriched in resting B cells 
[16], stained positively._ Thus, activated B cell s accounted for 
the staining observed m the T cell - and monocyte-depleted 
PBMC population. . . . . 
In order to establish the Ident ity of the antigen recogm zed 
by EL-2 to that defined by ~F2, sequentia~ immunoprecipitat i_on 
alysis was performed usmg lactoperoxidase-catalyzed, radio-~:dinated membrane extracts of t he T lymphoblastoid cell line 
CEMT. The resul ts are shown in Fig 1. In previous experiments 
both EL-2 and 4F2 imm~~oprecipitated a 120 kD hete :odi~er 
under nonreducing conditions from CEMT cells. Corr_u ?Tatmg 
80 a nd 40 kD bands were seen under :educ_ing conditiOn~ as 
also shown here in lanes 3 and 4. The Identity of the antigen 
precipitated by t hese two ~nonoclonal ant ibodies was_ further 
demonstrated by sequential 1mmunoabsorptwns With 4F2 
(la n es 5-8), EL-2 (not sh?wn), and sham absorpt ions (la_nes 1-
4) as described in Matenals and M~thods_. The con~rol Immu-
noprecipitates wit h FFA85 and antl-{32- microglobulm (lanes 1, 
2 5 6) are not affected by 4F2 absorption. In contrast, t he 
a~tigen immunoprecipitated by EL-2 (lane 3) is completely 
removed by 4F2 absorpt ion (lane 7), as is t he 4F2 antigen (lane 
8). In t he reverse sit uation , t he 4F2 antige ~ was a_ls? removed 
by EL-2 absorption (data not shown). Famtly VISible bands 
were present in a ll lanes at molecular M , 45,_000 and 12~000. 
These bands comigrated with HLA heavy cham and {32- micro-
globulin (lanes 2, 6) and appeared to be nonspecifi_c .. Whi~e it 
· s clear that t he protein recognized by EL-2 and 4F2 IS Identical, ~he possibili ty that these two antibodies may react with dif~er ­
ent epitopes of th is protein cannot be ruled out by these stud1es. 
I Sham absorbed II 4F2 absorbed I 
FFA {32M EL2 4F2 FFA {32M EL2 4F2 
85 85 









FIG 1. Monoclonal antibodies EL-~ and 4F2 immunoprecipi tate the 
same molecule. Sodium dodecyl sulfate 12.5% polyac rylamide gel pat-
tern of the immunoprecipitates obtained from 1251-labeled CEMT cells 
by monoclona l antibodies. All lanes were r~n under reducingconditions 
with 0.1 M dithiothreitol: The identity o! the antigen precipitated by 
monoclonal antibod ies EL-2 and 4F2 was demonstrated by sequential 
immunoabsorptions with 4F2 (lanes 5-8) and sham absorptions (lanes 
J-4) as described in detail in Materials and Methods. The control 
immunoprecipitates with monoclonal antibody FFA85 (lanes I , 5) and 
a monoclona l anti-~2-m i croglobuli n antibody (lanes 2, 6) are unaffected 
by 4F2 abso rption. In contrast, the antigen immunoprecipitated by EL· 
2 (lane 3) is completely removed by 4F2 absorption (lane 7) as is the 
4F2 antigen (lane 8). Faintly visible bands are present in all Janes at 
M, 45 and 12 kD. These bands comigrated with HLA heavy chain and 
{32-rn icroglobulin (lanes 2, 6) and appear to be nonspecific. 
EL-2 Reacts with Basal Keratinocytes and Cultured 
Mela.nocytes 
The reactivity of antibody EL-2 with normal human skin 
was tested by immunoperoxidase staining, and the results are 
shown in Fig 2a.. Only the basal epidermal layer stained posi-
t ively. In other experiments, t his antibody reacted with basal 
epithelial cells in eccrine sweat glands, sebaceous glands, and 
hair follicles. These appendages are developmentally derived 
from basal epidermal cells. The membrane pattern of reactivity 
is clearly shown in Fig 2b, which illustrates t he reactivity of 
EL-2 with an invasive squamous cell carcinoma of the squirrel 
monkey oral cavity. EL-2 was also reactive with tissue sections 
from 5 human basal cell carcinomas and the epidermoid carci-
noma line, A431. This antibody is being used to characterize 
disorders of keratinocyte differentiation whose etiologies are as 
yet unknown. Lesional skin from a patient with psoriasis was 
tested for reactivity with EL-2, and the results are shown in 
Fig 2c. As has been reported with monoclonal antibody 4F2 
[8], only the basal layer stained with EL-2. The same results 
(i.e., staining of t he basal layer only) were obtained wit h lesional 
skin from 4 other psoriasis patients and from patients with two 
other disorders of keratinization , pityriasis rubra pilaris and 
Darier's disease (data not shown). It was impossible to deter-
mine in t issue sections whether melanocytes, which account 
for 1 out of every 10- 12 cells in the basal layer, also were 
reactive. T herefore, cu ltured neonatal foreskin melanocytes 
were sta ined with an t ibody EL-2 and another basal kerati no-
cyte-spec ific monoclonal antibody, EL-l. EL-l was produced 
by the same fusion as EL-2. It recognizes a 105 kD membrane 
protein expressed by a subset of immature lymphocytes and 
epidermal basal keratinocytes (6]. The results are shown in Fig 
3. EL-2 showed clear membrane reactivity with formalin-fixed 
melanocytes (Fig 3b ). One hundred percent of the cells scored 
were reactive. In other experiments, t he same results were 
obta ined with ant ibody 4F2. In contrast, EL-l , which also 
reacts with basal keratinocytes, did not stain cultured melan-
ocytes (Fig 3d). T hese resul ts were confirmed in 2 additional 
experiments. In all 3 cases, rapidly growing melanocytes were 
tested. Both pigmented and nonpigmented melanocytes were 
reactive with EL-2 and 4F2. 
Purification and Culture of Basal Keratinocytes 
Since EL-2 reacted wit h a membrane antigen expressed only 
on basal keratinocytes, it was selected to separate epidermal 
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FIG 2. lmmunoperox idase staining of skin with monoclonal anti-
body EL-2. Three sections are shown. Scale bars = 10 11m. a, Normal 
human sk in; only epidermal basal kera tinocytes stain positively. b, 
Squirrel monkey invasive squamous cell carcinoma of the oral cavity; 
EL-2 demonstrates a membrane reactivity pattern. c, Lesional human 
psoriasis skin ; only epidermal basal keratinocytes stain positively. 
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FIG 3. Fluorescent staining of cultured melanocytes by monoclonal 
antibodies. X 630. EL-2, b; EL-l, d; a and c show phase contrast. 
TABLE II. Pu.ri[£ca.tion of epidermal basal heratinocytes with EL-2 
Immunoflu orescence(% 
Keratinocyte posit ive)" 
subpopulation 
GAM" a lone EL-2 HC- 1 
Exp 1 Unseparated 44 42 0 
Pellet (basal ce ll - 96 93 0 
enriched) 
In terphase (basal 12 6 0 
cell -depleted) 
Exp 2 Unseparated 34 46 0 
Pellet 91 98 0 
Interphase 0.5 11 0 
" By indirect immunof'luorescence as described in Table I. 
"GAM = tetra -methyl-rhodam ine- isothiocyanate-conjugated Fab'" 
fragments of a goat anti mouse IgG antise rum. 
s ingle-cell suspensions of epidermal cells derived from neonatal 
cadaver skin . Purity of the basal cell population was assessed 
by reactivity of epidermal subpopu lations with monoclonal 
a ntibodies EL-2 and HC-1. HC-1 detects an antigen expressed 
on hairy cell leukemia cells, endothelial cells, and basal kera-
t inocytes that is clearly different from that defined by EL-2 in 
both its staining and biochemical characteristics. It was there-
fore chosen as second reagent to quantitate the number of basal 
cells in each cell fraction because staining with HC-1 would 
not be affected by the isolation procedure itself [7] . The results 
a re shown in Table II. The average yield of basal keratinocytes 
was 71 % of the cells subjected to rosetting, and the average 
viability was 81%. In both expe riments, the basal keratinocyte-
enriched pellet was > 90% positive with the monoclonal anti-
bodies EL-2 and HC-1. In contrast, the basal keratinocyte-
depleted interphase contained <12% cells reactive with these 
two antibodies. The positive staining in both the pellet and 
interphase populat ions was not due to residual monoclonal 
antibody carried over from the rosetting procedure. No staining 
was observed with tetra-methyl-rhodamine- isothiocyanate-
conjugated Fab' 2 fragments of a goat antimouse lgG antiserum 
alone. In addition, another IgG"" K monoclonal antibody, EL-
4, with specificity for an antigen found in the stratum corneum 
(Gottlieb, unpublished observation), did not stain. The per-
centage of contam inating Langerhans cells in the basal kera-
tinocyte-enriched pellet was 3% as compared with 0.4% and 
none in the unseparated and interphase keratinocyte popula-
tions, respectively. There was <1% melanocyte and fibrobl ast 
contamination in all subpopulations. 
In a representative experiment, an equal number of isolated 
basal and unseparated kerat inocytes were cu ltured in 9.6 cm2 
wells. At days 5, 12, and 19 Of culture, cells were trypsinized, 
counted, and tested for EL-2 reactivity by indirect immunoflu-
Vol. 85, No.4 
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FIG 4. In vitro growth of purified basal ce lls as compared with 
unseparated kerat inocytes. Left ordinate represents the total number 
of cells per culture (0----0 = unseparated cells; 6.--6. = basal cells); 
right ordinate represents the proportion (%) of EL-2-reactive cells as 
determined by indirect immunofluorescence (.____. = unseparated 
cells; .A.--.6. =basal cells). 
orescence. The viability of these cells was 80-99% by trypan 
blue dye exclusion. The results are shown in Fig 4. Cultures of 
isolated basal cells contained a higher proportion of basal cells 
than did those from unseparated keratinocytes throughout the 
entire culture period. For both basal and unseparated keratin-
ocytes the proportion of EL-2-positive cells peaked at day 12. 
These results confirm previous observations using frequency 
distribution histograms of the DNA content of individual cells 
and [3H]thymidine incorporation [17]. When t hese same cells 
were stained with toluidine blue, the proportion of EL-2-posi-
tive cells correlated well with the estimated proportion of cells 
with high nuclear/cytoplasmic ratios. This is consistent with 
the fact that EL-2 stains basal keratinocytes. Surprisingly, the 
total number of cells obtained by t rypsinization of basal and 
unseparated keratinocyte cultures did not differ significantly. 
It may be that purified basal keratinocytes have optimal culture 
conditions which differ from those that have been developed 
for unseparated keratinocytes. Studies are in progress to deter-
mine whether this is indeed the case. 
DISCUSSION 
In this report we have described a monoclonal antibody, EL-
2, which detects the same antige n as does antibody 4F2. How-
ever, the possibility that both antibodies detect different epi-
topes of the same glycoprotein cannot be ruled out. We have 
extended previous observations by demonstrating that the re-
activity of both these antibodies with the basal epidermal layer 
is with melanocytes in addition to keratinocytes. We are cur-
rently in the process of testing dysplastic nevi, melanomas, and 
melanoma cell lines for reactivity with EL-2. The demonstra-
tion of melanocyte staining by EL-2 and 4F2 is an important 
observation, because previous investigators had reported the 
epidermal reactivity of 4F2 so lely with basal keratinocytes and 
did not investigate melanocyte reactivity [8]. As a result of our 
experiments, any future hypothesis for the function of the 
antigen defined by EL-2 (or 4F2) will have to take into account 
the fact that both basal keratinocytes and melanocytes are 
reactive. 
EL-2 is being applied to the study of disorders of keratinocyte 
differentiation whose etiologies are as yet unknown. Basal and 
squamous cell carcinomas were reactive with EL-2. Tissue 
sections from lesional skin from patients with psoriasis, pity-
riasis rubra pilaris, and Darier's disease showed reactivity with 
only t he basal layer. This is despite t he fact that suprabasilar 
keratinocytes are labeled with [3H]thymidine in lesional pso-
riasic skin [22]. We speculate that the antigen recognized by 
EL-2 may be important in maintaining basal keratinocyte and 
melanocyte attachment to the basement membrane as opposed 
to stem cell proliferation and differentiation. 
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The function of t he a n tigen detected by EL-2 a nd 4F2 is 
incompletely understood. Certain observations suggest t hat it 
is a n activation a nt igen: lymphocytes activated by mitogens 
and antigens, a nd lymphoid and nonlymphoid m align a nt cell 
l ines were reactive with EL-2. Resting ly mphocytes were n eg-
ative. This a n t igen is clearly not sole ly stem cell -associated, 
since Lavker a nd S un h ave demonstrated t hat epidermal stem 
cells are concen t rated in t h e rete ridges and not uniformly 
distributed t hroughout t he basal layer [23 ]. However , stem cells 
were enumerated by autoradiographic techniques which meas-
ured on ly ["H]thym idine uptake. One can speculate that a l-
thou gh most basal keratinocytes do not demonstrate significant 
labeling wi t h ['1H] t hymidine, they may be "activated ," possib ly 
by factors secreted by .the ~tern cells them.selves. Th.is would 
account for t he reactJVJ ty of a ll basa l keratmocytes w1th EL-2 
a nd 4F2. Studies of lymphocyte activation h ave been enhan ced 
by t h e availability of monoc lon a l a ntibody-defined activat ion 
antige n s [24]. S imila rly, a n t ibodies EL-2 (and 4F2} m~y be 
useful in establishing t he concept of ke ratinocyte activation. 
Using EL-2 a nd a m odified rosetting technique, basal kera-
ti nocytes were isolated to greate r t han 90% purity a nd success-
fully cultured in vitro. These results represen t a n improvement 
over previous studies: Brysk et a l [2] used discon t inuous iso-
kinetic c:rra di ents of PERCOLL to separate newborn rat epider-
mal ce ll~ and demonst rated t hat t he ir basal cell-enrich ed frac-
tion was 98% viable, but t hey did not specify the exact purity 
of t his fract ion. Morhenn et a l [1] ac hieved basal cell-enriched 
populations of 90% puri ty wi t h monoclonal a n tibody VMl but 
were unable to su bsequently culture these cells successfully. In 
o ur experiments, s ignifican t melanocyte contamination did not 
occur desp ite t h e fact t hat EL-2 reacted with both mel anocytes 
a nd basal keratinocytes. The reason for this observation is that 
the conditions used to dissociate epide rmal cells from skin, and 
the re latively mela nocyte-poor areas of ski n selected for study 
(extremities a nd bac k) resulted in < 1% melanocyte contami-
nation. In addit ion , the culture condition s used were not favor-
able for melanocyte growth [11 ,17] . 
This is the first applicatio n of rosetting technology to t he 
iso lation of ke ratinocyte subpopulat ion s. It h as been demon-
strated to be efficacious in both the enrichment and deplet ion 
of epidermal basal ke rat inocytes. Cul t ures of purified basal 
cells mainta ined higher proportions of EL-2-reactive cells (i.e., 
basal cells) t hroughout t he entire culture period as compa red 
with t hose of unseparated ke ratinocytes. 
Recently a number of investigators have reported the use of 
a u tologous cult ured ep idermal cells as grafts to replace sk in 
lost by burn injuries [25,26] and as grafts to cover nonhealing 
wounds [27,28]. These grafts were made by culturing unpurified 
epidermal keratinocytes. The use of cul tures of purified basa l 
keratinocytes should be con s idered, s ince such populations may 
be enriched in proliferating cells. Pat ients with epidermolys is 
b ullosa and individua ls with n onhea ling wounds represen t can-
didates for au tologous grafts wit h such purified basal kerat in -
ocytes. The efficacy of such grafts could be compared with 
cultures established from a utologous unpurified epidermal ker-
atinocytes. Purification of basal keratinocytes will a lso be im-
portant in biochemica l a nd functional studies of norma l skin 
a nd in establishing long-term keratinocyte lines from normal 
keratinocytes. 
The authors would like to thank Ms. Ann Hoy and Ms. Jeannine 
Acocella for their excellent. technical assistance. 
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